نتایج جستجو برای: lanthanum based perovskites

تعداد نتایج: 2941049  

Journal: :Cellular & molecular immunology 2004
Yang Wang Fei Guo Feng Hu Gongxian Wang Guohui Li

To investigate the effects of lanthanum chloride on binding of LPS to monocyte and CD 14 expression upregulation induced by LPS, human monocytes were analyzed by flow cytometry (FCM). The results indicated that lanthanum chloride could decrease the binding rate of LPS with monocyte significantly. LPS upregulated the expression of CD 14 on monocyte in a dose dependant manner, however, lanthanum ...

2017
Bryan A. Rosales Michael P. Hanrahan Brett W. Boote Aaron Rossini Emily A. Smith Aaron J. Rossini Javier Vela

Hybrid lead perovskites containing a mixture of organic and inorganic cations and anions have led to solar cell devices with performance and stability that are better than those of their single-halide analogs. 207Pb solidstate nuclear magnetic resonance and single-particle photoluminescence spectroscopies show that the structure and composition of mixed-halide and likely other hybrid lead perov...

Journal: :Clinical journal of the American Society of Nephrology : CJASN 2007
Priscilla P How James H Fischer Jose A Arruda Alan H Lau

BACKGROUND AND OBJECTIVES Phosphate binders such as calcium salts or sevelamer, a cationic polymer, can markedly reduce absorption of oral ciprofloxacin. This randomized, open-label, two-way, crossover study examined the influence of the cation lanthanum on systemic ciprofloxacin exposure after oral administration. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS Twelve patients randomly receive...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004
Alastair J Hutchison Mary Speake Fouad Al-Baaj

BACKGROUND The majority of patients with end-stage renal disease on dialysis are hyperphosphataemic. Lanthanum carbonate has been shown to be a highly effective phosphate binder in pre-clinical studies. A 4-week, open-label, dose-titration trial was conducted to assess the ability of lanthanum carbonate to control phosphate levels in patients with chronic renal failure. METHODS This prelimina...

2008
Juliette Thariat Vincent Launay-Vacher Antoine Italiano José Santini Frederic Peyrade

Correction of metabolic acidosis after conversion from sevelamer hydrochloride to lanthanum carbonate Sir, We recently introduced lanthanum carbonate as an alternative phosphate binder to sevelamer hydrochloride in patients with elevated serum calcium. Lanthanum carbonate has a higher affinity for phosphate than sevelamer HCl, so fewer lanthanum carbonate tablets are required to achieve the sam...

2017
Yaoguang Rong Xiaomeng Hou Yue Hu Anyi Mei Linfeng Liu Ping Wang Hongwei Han

Organometal lead halide perovskites have been widely used as the light harvester for high-performance solar cells. However, typical perovskites of methylammonium lead halides (CH3NH3PbX3, X=Cl, Br, I) are usually sensitive to moisture in ambient air, and thus require an inert atmosphere to process. Here we demonstrate a moisture-induced transformation of perovskite crystals in a triple-layer sc...

Journal: :The Journal of Physical Chemistry C 2018

Journal: :Clinical journal of the American Society of Nephrology : CJASN 2009
Stuart M Sprague Hanna Abboud Ping Qiu Matthew Dauphin Pinggao Zhang William Finn

BACKGROUND AND OBJECTIVES Lanthanum carbonate (FOSRENOL, Shire Pharmaceuticals) is an effective noncalcium, nonresin phosphate binder for the control of hyperphosphatemia in chronic kidney disease (CKD) stage 5 patients undergoing dialysis. DESIGN, SETTING, PARTICIPANTS AND MEASUREMENTS A Phase 2, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of lanthan...

2012
Takashi Shigematsu Yuri Nakashima Masaki Ohya Koichi Tatsuta Daisuke Koreeda Wataru Yoshimoto Shintaro Yamanaka Toshifumi Sakaguchi Yoshiyuki Hanba Toru Mima Shigeo Negi

Hyperphosphatemia has been shown to be involved not only in the onset and progression of secondary hyperparathyroidism but also in vascular calcification. In addition, it influences the clinical course of patients with chronic kidney disease. Phosphate (Pi) binder is required in the management of hyperparaphosphatemia, because dietary Pi restriction and Pi removal by hemodialysis alone are insu...

2011
Stephen JP Damment

Studies were conducted to compare the phosphate-binding efficacy of lanthanum carbonate directly with other clinically used phosphate binders and to evaluate any potential adverse pharmacology. To examine the phosphate-binding efficacy, rats with normal renal function and chronic renal failure received lanthanum carbonate, aluminum hydroxide, calcium carbonate, or sevelamer hydrochloride in sev...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید